Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 21 EP applications Jörg Velker has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12791862

2-(1,2,3-TRIAZOL-2-YL)BENZAMIDE AND 3-(1,2,3-TRIAZOL-2-YL)PICOLINAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/5377, C07D 417/14, C07D 413/14, C07D 413/10, A61P 25/30, A61P 25/26, A61P 25/22, A61P 3/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13744805

BENZIMIDAZOLE-PROLINE DERIVATIVES

IPC classification:
A61K 31/505, A61K 31/426, A61K 31/4184, C07D 417/14, C07D 403/04, C07D 401/14, A61P 25/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP13197481

Stereoselective synthesis of substituted pyrrolidines

IPC classification:
C07D 491/08, C07D 207/16, C07D 207/12, C07B 53/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15154003

Oxazolidinone antibiotics

IPC classification:
A61K 31/435, C07D 471/04, A61P 31/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP13805561

OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO)ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES

IPC classification:
A61K 31/41, C07D 419/14, C07D 419/04, C07D 417/14, C07D 417/04, C07D 413/14, C07D 413/04, C07D 403/14, C07D 403/04, C07D 401/14, A61P 25/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
GRANT OF PATENT INTENDED
EP15154086

Oxazolidinone antibiotics

IPC classification:
A61K 31/435, C07D 471/04, A61P 31/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
PATENT GRANTED
EP14714392

AZETIDINE AMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/00, C07D 417/14, C07D 413/04, A61K 31/433, A61K 31/427, A61K 31/4245, A61K 31/422, A61K 31/4196, A61K 31/4192, A61K 31/4178, A61K 31/4155, A61K 31/397, C07D 413/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION IN PROGRESS
EP14721539

ANTIBACTERIAL BIAROMATIC DERIVATIVES

IPC classification:
A61P 31/00, C07D 513/04, C07D 498/04, C07D 417/14, C07D 417/04, C07D 413/04, A61K 31/542, A61K 31/5415, A61K 31/5383, A61K 31/538, C07D 413/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP14726420

QUINOLONE DERIVATIVES

IPC classification:
A61P 31/04, A61K 31/4353, A61K 31/429, A61K 31/424, C07D 519/00, C07D 513/04, C07D 498/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION IN PROGRESS
EP14730591

CXCR7 RECEPTOR MODULATORS

IPC classification:
A61K 31/455, C07D 211/56, C07D 405/12
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP14799475

TRICYCLIC IMIDAZOLE COMPOUNDS AS INHIBITORS OF TRYPTOPHAN HYDROXYLASE

IPC classification:
A61P 25/00, A61P 9/12, A61P 3/10, A61P 1/00, A61P 35/00, A61P 19/10, A61P 11/00, A61K 31/4545, A61K 31/454, A61K 31/4535, A61K 31/453, C07D 513/14, C07D 498/12, C07D 471/14, C07D 471/04
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP14799473

TRICYCLIC PIPERIDINE COMPOUNDS

IPC classification:
A61P 11/06, A61K 31/437, C07D 513/14
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP14824107

CRYSTALLINE FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1 -YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AND ITS USE AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/00, A61K 31/4192, C07D 403/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP14824108

CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1 H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1 -YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AS OREXIN RECEPTOR ANTAGONIST

IPC classification:
A61P 25/00, A61K 31/4192, C07D 403/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP14827273

USE OF BENZIMIDAZOLE-PROLINE DERIVATIVES

IPC classification:
A61P 25/00, A61K 31/506, A61K 31/4192, A61K 31/4178, C07D 403/14
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION REQUESTED
EP12709375

NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS

IPC classification:
A61P 25/00, A61K 31/4155, A61K 31/4178, A61K 31/422, C07D 417/14, C07D 417/12, C07D 413/14, C07D 413/12
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15706185

PROCESS FOR MANUFACTURING PYRIMIDINE SULFAMIDE DERIVATIVES

IPC classification:
C07D 401/12
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
EXAMINATION REQUESTED
EP15778983

ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH AMINOALKOXY SUBSTITUTION

IPC classification:
A61P 31/04, A61K 31/5365, C07D 498/04, C07D 417/14
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
Request for examination was made
EP15801263

ANTIBACTERIAL BENZOTHIAZOLE DERIVATIVES

IPC classification:
A61P 31/04, A61K 31/428, C07D 277/62
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
Request for examination was made
EP15801467

CXCR7 RECEPTOR MODULATORS

IPC classification:
C07D 267/14, C07D 243/14, A61K 31/553, A61K 31/5513, A61K 31/55, C07D 223/16
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
Request for examination was made
EP16797577

N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS

IPC classification:
A61P 15/00, A61P 11/00, A61P 9/00, A61P 25/00, A61P 35/00, A61K 31/506, C07D 417/14, C07D 409/14, C07D 403/14, C07D 413/14, C07D 403/12
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
Request for examination was made

Please Sign in to use this feature